RxSight, Inc. (RXST) Return on equity 2021–2025
RxSight, Inc. (RXST) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-14.1%FY2025 · since FY2021: -35.2% → -14.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -14.1% | -4.4 pp |
| FY2024 | -9.8% | +20.5 pp |
| FY2023 | -30.3% | +43.9 pp |
| FY2022 | -74.3% | -39.0 pp |
| FY2021 | -35.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice